VANCOUVER, British Columbia, April 12, 2021 (GLOBE NEWSWIRE) -- The global RNA transcriptomics market size is expected to reach USD 12.46 Billion in 2028 and register a steady CAGR during the forecast period, according to latest analysis by Emergen Research. Some key factors driving market revenue growth include rising demand for customized and personalized medicines, increasing investments in biotechnology and pharmaceutical research, rising prevalence of gene mutations that are continuously occurring in cancer genes and genetic variations, and constant developments in medical infrastructure. RNA Transcriptomics provides a proper analysis of the entire RNA transcript which is present in an individual cell or cell population. This analysis thoroughly examines all the elements of the transcript to identify the transcriptional structure of genes and analyze the changing nature or behavior of each transcript under multiple development stages.
Claim Your FREE Sample Copy with Table of content@ https://www.emergenresearch.com/request-sample/610
Various methods have been developed to perform transcriptome analysis such as microarrays, RNA interference, SAGE, polymerase chain reaction, and others. Polymerase chain reaction is a method that is used to make multiple copies of specific genes to identify and analyze a short sequence of RNA and DNA. These methods help scientists learn about diseases at a genomic level, which will help to develop clinical biomarkers, and identify and investigate multiple drug efficiency.
Some Key Findings from the Report:
- In February 2019, Caris Life Sciences launched MI Transcriptome, which is a next-generation sequencing-based assay designed to detect and characterize molecular features of cancer cells to find more precise individualized treatment therapies for patients.
- Drug discovery segment accounted for a significantly higher revenue share in the global market in 2020. This can be attributed to increasing application of transcriptomics in drug discovery and for studying the efficacy of drugs.
- North America accounted for a revenue share of 32.2% in the global market in 2020. This can be attributed to rapid development of structure-based drug designs, growing focus on genomics and proteomics research, and rising expenditure on biopharmaceutical research.
- Key players operating in the market are Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Merck KGaA, Agilent Technologies, Inc., Illumina, Inc., GenXPro GmbH, Fluidigm Corporation, CD Genomics, Sequentia Biotech SL, and Acobiom.
Check Our Prices@ https://www.emergenresearch.com/select-license/610
For the purpose of this report, Emergen Research has segmented the global RNA transcriptomics market based on product, technology, application, end-use, and region:
- Product Outlook (Revenue: USD Billion; 2018–2028)
- Reagents
- Instruments
- Software
- Service
- Technology Outlook (Revenue: USD Billion; 2018–2028)
- Microarrays
- Polymerase Chain Reaction
- RNA Sequencing
- RNA Interference
- Application Outlook (Revenue: USD Billion; 2018–2028)
- Clinical Diagnostics
- Toxicogenomics
- Drug Discovery
- Comparative Transcriptomics
- End-use Outlook (Revenue: USD Billion; 2018–2028)
- Hospitals
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations
Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends: https://www.emergenresearch.com/industry-report/rna-transcriptomics-market
- Regional Outlook (Revenue: USD Billion; 2018–2028)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- BENELUX
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- South Korea
- India
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Turkey
- Rest of MEA
- North America
Take a Look at our Related Reports:
Topical Drug Delivery Market By Product Form (Semi-Solid, Solid Formulations, Transdermal Products, and Liquid Formulations), By Route (Dermal, Ophthalmic, Nasal, Others), By End-Use (Hospitals, Home Healthcare, Clinics, Diagnostic Centers, Burn Center), and By Regions
Medical Smart Textiles Market By Technology (Textile Sensors, Wearable Technology), By Application (Surgery, Bio-Monitoring, Therapy, and Wellness), By End-use (Hospitals and Clinics, Medical Academic and Research Center), and By Region
Operating Room Management Solutions Market By Solution Type (Data management and communication solutions, Operating room supply management solutions, Anesthesia information management solutions, Operating room scheduling solutions, Performance management solutions), By Mode of Deployment (Ob-premises, Cloud-based), By End-Use (Hospitals, Ambulatory surgical centers), and By Region
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Facebook | LinkedIn | Twitter | Blogs
Read Full Press Release@ https://www.emergenresearch.com/press-release/global-rna-transcriptomics-market